Utrup L J, Moore T D, Actor P, Poupard J A
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454.
Neither amoxicillin nor clavulanic acid used alone was active at the highest level tested, i.e., 256.0 micrograms/ml, in vitro against 24 isolates of Mycobacterium fortuitum, Mycobacterium kansasii, and Mycobacterium marinum. However, the MIC of an amoxicillin-clavulanic acid combination of 2:1 was < or = 8.0/4.0 micrograms/ml for 50 percent of the isolates tested, with all isolates being inhibited in the range of 4.0/2.0 to 32.0/16.0 micrograms/ml, respectively. Titration of amoxicillin-clavulanic acid with a fixed 2-micrograms/ml concentration of ethambutol resulted in synergistic activity against 3 of 9 isolates of M. fortuitum, 10 of 10 isolates of M. kansasii, and 5 of 5 isolates of M. marinum. This observation was confirmed in a checkerboard analysis in which fractional inhibitory concentrations were < or = 0.5 for 20 of the 24 isolates. Synergistic activity was observed against the other four isolates in one of two trials. On the other hand, titration of amoxicillin-clavulanic acid in the presence of either one or two fixed concentrations of isoniazid, rifampin, cycloserine, tetracycline, or amikacin failed to result in synergism.
单独使用阿莫西林或克拉维酸在体外对24株偶然分枝杆菌、堪萨斯分枝杆菌和海分枝杆菌进行测试时,在最高测试浓度即256.0微克/毫升时均无活性。然而,对于50%的受试菌株,阿莫西林与克拉维酸比例为2:1的组合的最低抑菌浓度≤8.0/4.0微克/毫升,所有菌株分别在4.0/2.0至32.0/16.0微克/毫升的范围内被抑制。用固定浓度2微克/毫升的乙胺丁醇滴定阿莫西林-克拉维酸,对9株偶然分枝杆菌中的3株、10株堪萨斯分枝杆菌中的10株和5株海分枝杆菌中的5株产生协同活性。在棋盘分析中证实了这一观察结果,其中24株菌株中有20株的部分抑菌浓度≤0.5。在两项试验中的一项中,观察到对其他四株菌株有协同活性。另一方面,在存在一种或两种固定浓度的异烟肼、利福平、环丝氨酸、四环素或阿米卡星的情况下滴定阿莫西林-克拉维酸未能产生协同作用。